Moving from autologous to allogeneic

Grab a coffee and start your day with the CGT Catapult Morning Tips webinar series exploring the latest challenges and solutions in ATMP development and manufacturing.

In this webinar, you will discover novel approaches in moving from autologous to allogeneic cell therapies and consider the main advantages and disadvantages of these approaches.

Speakers include:

  • Mustafa Munye, Lead Scientist, CGT Catapult 
  • Alessandra De Riva, Director of Process Development, Mogrify

Register today!

Discover who we are